Zenas BioPharma to host virtual R&D event on pipeline updates
ZBIO•Zenas BioPharma will host a virtual R&D event on Oct. 27, 2026, from 8:00 a.m. to 9:30 a.m. ET, covering its pipeline, including obexelimab in systemic lupus erythematosus and development of ZB021.
1. Event details
Zenas BioPharma will host a virtual R&D event on Oct. 27, 2026, from 8:00 a.m. to 9:30 a.m. ET. Management will outline the R&D pipeline, focusing on obexelimab in systemic lupus erythematosus and providing updates on development of ZB021, an oral IL-17AA/AF inhibitor.
